|Description||AB-423 is a small-molecule inhibitor of HBV core protein used to treat chronic HBV infection. In preclinical study, AB-423 was indicated to damage assembly of the viral capsid (IC50 = 3 mcM). In mouse model, it led to a significant reduction of the viral DNA level.|
|Brife Description||inhibitor of HBV, chronic HBV infection|
|Application||the treatment of chronic HBV infection|
|Current Developer||Arbutus Biopharma|
Bay 41-4109 less active enantiomer
Bay 41-4109 less active enantiomer exhibits less activity than Bay 41-4109 that is a novel class of drugs and inhibits hepatitis B virus (HBV) capsid formation ...
An oral antiviral drug used in the treatment of hepatitis B infection. A guanine analogue that inhhibits all three steps in the viral replication process.
Helioxanthin derivative 5-4-2
Helioxanthin derivative 5-4-2 had potent anti-HBV activities in HepG2.2.15 cells, with the EC50s of 1 and 0.08 microM, respectively. The lamivudine-resistant HB...
AB-423 is a small-molecule inhibitor of HBV core protein used to treat chronic HBV infection. In preclinical study, AB-423 was indicated to damage assembly of t...
Lagociclovir is a prodrug of 3'-fluoro-2',3'-dideoxyguanosine with high oral bioavailability in humans and potent activity against HBV.
Adefovir Dipivoxil is a reverse transcriptase inhibitor, used in the treatment of chronic hepatitis B virus (HBV).
Clevudine is metabolized in cells by the cellular thymidine kinase as well as deoxycytidine kinase to its monophosphate, and subsequently to the di- and triphos...
Bicyclol is a anti-hepatitis drug, used in China for chronic hepatitis B and presumably C.
Helioxanthin 8-1 is an analogue of helioxanthin, which exhibites significant in vitro anti-HBV/HCV/HSV-1/HIV activity. It showed the most potent antiHBV activi...
Helioxanthin and its analogues decreased cellular RNA levels of HBV and antigen expression as well as selective inhibition of HBV replication in a cell culture ...
Merimepodib is orally bioavailable IMPDH inhibitor.
ABI-H-0731 is one of a class of novel and oral CpAMs developed for the potential use to treat chronic hepatitis B virus infection and disorders associated with ...
Telbivudine is an antiviral drug used in the treatment of hepatitis B infection. It is marketed by Swiss pharmaceutical company Novartis under the trade names S...
Entecavir-triphosphate is a highly potent inhibitor of wild-type HBV Pol and is 100- to 300-fold more potent than lamivudine-triphosphate against 3TC-resistant ...